Kasten Inc

PINK:KAST USA Engineering & Construction
Market Cap
$267.42K
Market Cap Rank
#50302 Global
#15357 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$1.58
About

Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need phar… Read more

Kasten Inc (KAST) - Net Assets

Latest net assets as of December 2024: $220.51K USD

Based on the latest financial reports, Kasten Inc (KAST) has net assets worth $220.51K USD as of December 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($785.39K) and total liabilities ($564.88K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $220.51K
% of Total Assets 28.08%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 211.16

Kasten Inc - Net Assets Trend (2013–2024)

This chart illustrates how Kasten Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Kasten Inc (2013–2024)

The table below shows the annual net assets of Kasten Inc from 2013 to 2024.

Year Net Assets Change
2024-12-31 $220.51K -22.29%
2023-12-31 $283.78K +2632.36%
2017-12-31 $-11.21K +3.34%
2016-12-31 $-11.59K +2.23%
2015-12-31 $-11.86K -444.61%
2014-12-31 $3.44K +135.05%
2013-12-31 $-9.82K --

Equity Component Analysis

This analysis shows how different components contribute to Kasten Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2556000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $41.14K 18.66%
Other Components $215.05K 97.52%
Total Equity $220.51K 100.00%

Kasten Inc Competitors by Market Cap

The table below lists competitors of Kasten Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Kasten Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 283,776 to 220,514, a change of -63,262 (-22.3%).
  • Net loss of 63,262 reduced equity.
  • Other comprehensive income increased equity by 41,141.
  • Other factors decreased equity by 41,141.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-63.26K -28.69%
Other Comprehensive Income $41.14K +18.66%
Other Changes $-41.14K -18.66%
Total Change $- -22.29%

Book Value vs Market Value Analysis

This analysis compares Kasten Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.21x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 $0.00 $0.01 x
2014-12-31 $0.00 $0.01 x
2015-12-31 $0.00 $0.01 x
2016-12-31 $0.00 $0.01 x
2017-12-31 $0.00 $0.01 x
2021-12-31 $0.00 $0.01 x
2022-12-31 $0.00 $0.01 x
2023-12-31 $0.01 $0.01 x
2024-12-31 $0.01 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Kasten Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -28.69%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -20.66%
  • • Asset Turnover: 0.39x
  • • Equity Multiplier: 3.56x
  • Recent ROE (-28.69%) is below the historical average (-16.66%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 0.00% 0.00% 0.00x 0.00x $631.80
2014 -13.73% 0.00% 0.00x 2.35x $-2.07K
2015 0.00% 0.00% 0.00x 0.00x $-344.10
2016 -134.68% 0.00% 0.00x 0.42x $-61.07K
2017 0.00% 0.00% 0.00x 0.00x $-36.51K
2021 0.00% 0.00% 0.00x 0.00x $517.00
2022 0.00% 0.00% 0.00x 0.00x $-16.79K
2023 27.15% 33.50% 0.27x 3.01x $48.68K
2024 -28.69% -20.66% 0.39x 3.56x $-85.31K

Industry Comparison

This section compares Kasten Inc's net assets metrics with peer companies in the Engineering & Construction industry.

Industry Context

  • Industry: Engineering & Construction
  • Average net assets among peers: $1,646,543,800
  • Average return on equity (ROE) among peers: 16.91%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Kasten Inc (KAST) $220.51K 0.00% 2.56x $62.24
Arcosa Inc (ACA) $2.43 Billion 3.86% 1.02x $5.06 Billion
Aecom Technology Corporation (ACM) $-181.00 Million 0.00% 0.00x $11.42 Billion
ACS Actividades de Construcción y Servicios S.A (ACSAF) $4.44 Billion 29.55% 6.70x $8.35 Billion
Acciona S.A (ACXIF) $6.30 Billion 7.00% 2.58x $3.04 Billion
Aecon Group Inc (AEGXF) $153.60 Million 7.49% 3.66x $737.44 Million
ÅF Pöyry AB (publ) (AFXXF) $551.78 Million 41.72% 1.52x $1.66 Billion
Abengoa S.A (AGOAF) $797.49 Million 15.10% 9.17x $1.82 Million
AF Gruppen ASA (AGRUF) $1.95 Billion 35.44% 2.36x $547.02 Million
Argan Inc (AGX) $3.70 Million 24.32% 1.27x $6.30 Billion
Amelco Corporation (AMLC) $15.28 Million 4.60% 1.62x $2.84